Min-Soo Kwon
Chief Executive Officer Brainimmunex
Kwon Min-Soo is the founder and CEO of Brainimmunex, a South Korean biopharmaceutical startup focused on developing small molecule therapeutics to rejuvenate senescent microglia and restore the brain’s natural defenses against brain aging-related neurodegenerative diseases.
Seminars
Wednesday 9th December 2026
Reversing Microglial Senescence via Metabolic Reprogramming to Restore Phagocytic Function & Promote Clearance of TDP‑43 Aggregates
4:00 pm
- Showcasing Brainimmunex’s novel approach to rejuvenating aged brains via metabolic reprogramming
- Demonstrating how rejuvenating senescent microglia leads to normal phagocytic function
- Presenting data from in vitro screening of microglial cultures and investigations in ALS drosophila and mice models
